comprehensive -WSS

comprehensive

author：fashion 2025-09-30 23:20:38 - browse：38

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

An oral version of semaglutide, the drug marketed as Ozempic and Wegovy, led to dramatic weight loss in a trial enrolling people with obesity, manufacturer Novo Nordisk said Monday, data that could bolster what is already a blockbuster medicine.

In the study, which enrolled nearly 700 adults classified as having overweight or obesity, patients treated with a daily semaglutide tablet lost 15.1% of their body weight over the course of 17 months, while those on placebo lost 2.4%, Novo Nordisk said. The result is comparable to weekly injections of Wegovy, which in an earlier study led to 14.9% weight loss over the same period of time. In both studies, the most common side effects were gastrointestinal distress, with the majority of cases graded mild or moderate, the company said.

Novo Nordisk said it plans to submit oral semaglutide for U.S. and E.U. approvals later this year. A lower-dose version of the drug is already approved as a treatment for type 2 diabetes under the brand name Rybelsus.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Medicare has a new plan to address drug shortages

explore

WSS

WHO calls for emergency meeting on new China virus, as cases spread

Biden tests positive for Covid

How dance can help nurses traumatized by Covid

Calls for Trump's election interference trial to be televised part of long debate

'Cuddling' is just what the doctor ordered for a 200

Prosecutors seek bail revocation for FTX founder Sam Bankman

focus

comprehensive

explore

Wildfire smoke exposes gaps in outdoor worker protections

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

After affirmative action ruling, medical educators look to 'holistic review'

As digital health tech proliferates, a new institute aims to cut through hype

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

The high cost of giving birth even with insurance

Medicare to cover more brain scans for Alzheimer’s patients

At least 13 dead in Texas as scorching temps continue

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

focus

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Prosecutors seek bail revocation for FTX founder Sam Bankman

Cosmetics set for new safety regulation. Why the industry is on board

WHO calls for emergency meeting on new China virus, as cases spread

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Medicare has a new plan to address drug shortages

leisure time

focus

explore

entertainment